NEWS | Feist-Weiller Cancer Center

Purple lines

   

Guardant Health Joins Forces with Faith Fight Finish Foundation and Feist-Weiller Cancer Center to Boost Colon Cancer Screening in Underserved Communities

Business Wire - Guardant Health, Inc., a leading precision oncology company, announced a collaboration with Dak Prescott’s Faith Fight Finish Foundation and the LSUHS mobile cancer screening program, Partners in Wellness, to increase colorectal cancer screening rates in northern and central Louisiana.

Read More about Guardant Health Joins Forces with Faith Fight Finish Foundation and Feist-Weiller Cancer Center to Boost Colon Cancer Screening in Underserved Communities (opens in new window/tab)
KEEL Radio News - LSU Health Shreveport starts two promising COVID Clinical Trials - image of scientist in the lab

LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.

Read More about March Biosciences and Cancer Focus Fund Announce $4.8 Million Investment to Support a Phase 2 Clinical Trial of Novel CAR-T Therapy for T-Cell Lymphoma (opens in new window/tab)
Dr. Gary Burton instructs staff at Feist-Weiller Cancer Center

Feist-Weiller Cancer Center, a Center of Excellence in Cancer Research, Treatment and Education at LSUHS and Loxo@Lilly, the oncology unit of Eli Lilly and Company, recently launched a new research collaboration that will provide next-generation sequencing (NGS) access to underserved cancer patients in the northern Louisiana region.

Read More about LSUHS, Loxo@Lilly Partner to Study Impact of Next-Generation Sequencing on Cancer Treatment Decisions and Patient Outcomes